UK pharma major AstraZeneca on Friday announced an agreement with US President Donald Trump’s administration to lower the ...

South Korea-based Celltrion on Friday announced that the US Food and Drug Administration (FDA) has approved Eydenzelt ...

US pharma major Bristol Myers Squibb has entered into a definitive agreement to acquire Orbital Therapeutics, a privately ...

German pharma major Bayer’s gene therapy subsidiary AskBio today announced initial safety data from the first cohort of ...

UK pharma major AstraZeneca announced that it will now invest $4.5 billion in its new manufacturing facility in Virginia, a ...

US biotech major Biogen and RNA medicine specialist Stoke Therapeutics have presented longer-term follow-up analyses from the ...

Spanish plasma-based medicines producer Grifols announced that Yimmugo, an innovative intravenous immunoglobulin (IVIg) ...

Swedish oncology specialist Xspray Pharma has received a complete response letter (CRL) from the US Food and Drug ...

India-headquartered Lupin has announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral ...

Expedition Therapeutics has closed a $165 million series A financing, just two months after acquiring global rights outside ...

US venture firm Ascenta Capital has closed its inaugural fund at $325 million, marking a significant milestone two years ...

An Expert View from Agnese Cattaneo, Chief Medical Officer at Angelini Pharma.